Metyrapone: Comprehensive Guide To Uses, Dosage & Side Effects
Comprehensive guide to metyrapone: uses in diagnosing and treating Cushing's syndrome, dosage, side effects, and precautions.
Metyrapone, also known as Metopirone, is a specialized medication primarily used for diagnosing and occasionally treating Cushing’s syndrome, a condition characterized by excessive cortisol production in the body.
| Type of medicine | A medicine which reduces the amount of cortisol and aldosterone produced by the body |
|---|---|
| Used for | The diagnosis or treatment of Cushing’s syndrome; The treatment of fluid retention associated with some kidney, liver, and heart conditions |
| Also called | Metopirone® |
| Available as | Capsules |
About metyrapone
Metyrapone is prescribed by specialist doctors, typically in a hospital setting, to manage conditions related to hormone overproduction. It works by inhibiting the enzyme 11-beta-hydroxylase in the adrenal glands, which blocks the final step in cortisol synthesis, thereby reducing cortisol levels in the body. This mechanism is crucial for both diagnostic testing and therapeutic control of hypercortisolism.
Cushing’s syndrome occurs when the body produces too much cortisol over a prolonged period. Cortisol, often called the “stress hormone,” plays vital roles in regulating blood pressure, immune response, and blood sugar levels. When levels are chronically elevated, symptoms such as weight gain (particularly around the abdomen and face), muscle weakness, easy bruising, thin skin, high blood pressure, and mood changes can develop. These symptoms are often nonspecific, making diagnosis challenging without specific tests like the metyrapone test.
In diagnostic use, metyrapone is administered as part of a challenge test to evaluate pituitary-adrenal axis function. A normal response involves a significant increase in precursor hormones like 11-deoxycortisol or 17-hydroxycorticosteroids (17-OHCS), indicating intact pituitary ACTH reserve. Subnormal responses may suggest pituitary dysfunction or adrenal insufficiency. For treatment, it helps control symptoms by preventing cortisol overproduction, especially in cases where surgery is not immediately feasible, such as ectopic ACTH production.
Additionally, metyrapone addresses fluid retention linked to excess aldosterone, a hormone that promotes sodium retention and water buildup. This is relevant in conditions like kidney disease, liver cirrhosis, or heart failure, where edema (swelling in feet or face) occurs due to hormonal imbalances.
The medication is available only as 250 mg capsules and requires careful monitoring due to its potent effects on hormone levels.
Before taking metyrapone
Prior to starting metyrapone, a thorough medical evaluation is essential to ensure safety. It is contraindicated in patients with known adrenal cortical insufficiency or hypersensitivity to metyrapone or its excipients, as it can precipitate acute adrenal crisis.
Inform your doctor if any of the following apply:
- You are pregnant, trying to conceive, or breastfeeding. Metyrapone may affect fetal development or pass into breast milk.
- You have underactive thyroid, pituitary, or adrenal glands, as these conditions can alter response to the drug.
- You have liver impairment, which may reduce metabolism and heighten effects.
- You have heart problems, particularly irregular heartbeat or heart failure.
- You have electrolyte imbalances, such as low sodium or high potassium.
- You have high blood pressure, which could worsen with hormonal shifts.
- You have porphyria, a rare blood disorder that may be exacerbated.
- You are taking other medications, including over-the-counter, herbal, or complementary therapies, as interactions can occur with drugs affecting pituitary or adrenal function (e.g., stop such drugs for at least 5 half-lives before testing).
- You have a history of allergic reactions to medications.
Patients with hepatic impairment, like cirrhosis, may show impaired responses, necessitating dose adjustments. Always disclose full medical history to avoid complications.
How to take metyrapone
Follow the manufacturer’s patient information leaflet supplied with the pack for detailed guidance on metyrapone use and side effects. Treatment begins under specialist supervision in a hospital. Dosage varies by purpose:
- Diagnosis: Typically 750 mg/m² body surface area in divided doses every 4 hours for 6 doses, often overnight, combined with other tests. Assess adrenal response to ACTH beforehand.
- Treatment: Initial doses of 250-500 mg three times daily, titrated based on cortisol levels, up to 8 g/day in severe cases.
Swallow capsules whole with water, at specified times. The label will confirm instructions. If a dose is missed, take it promptly unless near the next dose—then skip and resume schedule. Never double up.
Regular blood tests monitor cortisol, ACTH, electrolytes, and precursors to guide adjustments.
Getting the most from your treatment
Attend all doctor appointments for progress checks, including hormone assays and clinical assessments. Patients with ectopic Cushing’s syndrome on metyrapone face higher infection risk due to immunosuppression; discuss prophylactic antibiotics.
Lifestyle tips include a balanced diet low in sodium for fluid retention, stress management to support adrenal health, and monitoring blood pressure and weight.
Common side effects and management
| Side Effect | Advice |
|---|---|
| Feeling dizzy or sleepy | Do not drive or use tools or machines while affected |
| Feeling sick (nausea) or being sick (vomiting) | Stick to simple foods – avoid rich or spicy meals |
| Feeling dizzy or light-headed, especially when standing | Try getting up or moving more slowly. If faint, sit down for a few minutes |
Other potential effects include abdominal pain, loss of appetite, headache, or rash. Acute adrenal insufficiency signs (nausea, hypotension, weakness) require immediate medical attention. Report persistent issues promptly.
Frequently Asked Questions (FAQs)
Q: Who prescribes metyrapone?
A: Specialist doctors, usually endocrinologists in a hospital setting.
Q: Can metyrapone be used in children?
A: Yes, for diagnosing adrenal insufficiency, with dosage based on body surface area.
Q: What if I overdose on metyrapone?
A: Seek emergency help. Symptoms include severe nausea, hypotension, and electrolyte imbalances. Treatment involves hydrocortisone, saline, and glucose.
Q: Does metyrapone interact with other drugs?
A: Yes, avoid drugs affecting pituitary/adrenal function before testing. Inform your doctor of all medications.
Q: How long does treatment last?
A: Varies; diagnostic use is short-term (24 hours), treatment until underlying cause resolved.
Q: Is metyrapone safe during pregnancy?
A: Use only if benefits outweigh risks; consult your doctor.
This FAQ section addresses common patient concerns, optimizing for search queries like “metyrapone side effects” or “metyrapone dosage Cushing’s.”
Advanced Clinical Considerations
Expanding on diagnostics, the metyrapone test distinguishes pituitary-dependent from ectopic ACTH sources. Overnight administration (30 mg/kg) followed by morning plasma cortisol >11-deoxycortisol ratio assessment confirms suppression efficacy. In pediatrics, similar protocols apply with close monitoring.
For therapy in severe Cushing’s, combination with ketoconazole or mitotane enhances control pre-surgery. Monitor for hypoadrenalism, supplementing glucocorticoids as needed. Recent guidelines emphasize rapid cortisol normalization to mitigate cardiovascular risks.
Patient counseling stresses recognizing adrenal crisis symptoms: profound weakness, dehydration, confusion. Immediate hydrocortisone injection kits may be prescribed for at-risk patients.
References
- Metyrapone – Patient.info — Patient.info. 2023. https://patient.info/medicine/metyrapone-metopirone
- Metopirone US Prescribing Information — HRA Pharma. 2020-02. https://metopirone.com/wp-content/uploads/2019/11/Metopirone_US_PI-rev.02.2020.pdf
- Metopirone FDA Label — U.S. Food and Drug Administration. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012911s035lbl.pdf
- Metopirone Official Site — HRA Pharma. 2023. https://metopirone.com
- Metyrapone Capsules – Cleveland Clinic — Cleveland Clinic. 2023. https://my.clevelandclinic.org/health/drugs/18121-metyrapone-capsules
- Metopirone Patient Information Leaflet — Bioscientifica. 2022. https://library.bioscientifica.com/media/jeno4t2d/pi-emd114-metyrapone.pdf
Similar Articles
Read full bio of Sneha Tete
